Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Change in Cash (2021 - 2025)

Rxo's Change in Cash history spans 5 years, with the latest figure at -$8.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 60.0% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$17.0 million, down 156.67%, while the annual FY2025 figure was -$17.0 million, 156.67% down from the prior year.
  • Change in Cash reached -$8.0 million in Q4 2025 per RXO's latest filing, down from $7.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $166.0 million in Q2 2022 to a low of -$99.0 million in Q4 2023.
  • Average Change in Cash over 5 years is -$812500.0, with a median of $0.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: tumbled 4350.0% in 2022, then soared 340.0% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$2.0 million in 2021, then crashed by 4350.0% to -$89.0 million in 2022, then decreased by 11.24% to -$99.0 million in 2023, then skyrocketed by 79.8% to -$20.0 million in 2024, then surged by 60.0% to -$8.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Change in Cash are -$8.0 million (Q4 2025), $7.0 million (Q3 2025), and $3.0 million (Q2 2025).